By targeting DNMT1, RhoA/Cdc42, and E2F6, miR-185 has been shown to induce cell cycle arrest and apoptosis, in addition to inhibiting proliferation and invasion in cancer cell lines and xenograft mouse models of various cancers [40, 44, 46]. Here, RHOA is linked to cancer.